Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)

por Golabi, Pegah, Otgonsuren, Munkhzul, de Avila, Leyla, Sayiner, Mehmet, Rafiq, Nila, Younossi, Zobair M.
Publicado 2018

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease

por Younossi, Zobair M., Stepanova, Maria, Rafiq, Nila, Henry, Linda, Loomba, Rohit, Makhlouf, Hala, Goodman, Zachary
Publicado 2017

Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

por Golabi, Pegah, Stepanova, Maria, Pham, Huong T, Cable, Rebecca, Rafiq, Nila, Bush, Haley, Gogoll, Trevor, Younossi, Zobair M
Publicado 2018

Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease Using Noninvasive Tests From Primary Care and Endocrinology Real-World Practices

por Younossi, Zobair M., Pham, Huong, Felix, Sean, Stepanova, Maria, Jeffers, Thomas, Younossi, Elena, Allawi, Hussain, Lam, Brian, Cable, Rebecca, Afendy, Mariam, Younoszai, Zahra, Afendy, Arian, Rafiq, Nila, Alzubaidi, Nahrain, Ousman, Yasser, Bailey, Marc, Chris, Zik, Castillo-Catoni, Maria, Fozdar, Pratima, Ramirez, Maria, Husain, Mehreen, Hudson, Evis, Schneider, Ingrid, Golabi, Pegah, Nader, Fatema
Publicado 2021